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ABSTRAK 
 
PENGENALAN 
Penyakit glaukoma adalah penyebab kebutaan kekal terbesar di dunia, di mana penduduk Asia 
menyumbang kepada separuh dari bilangan kes-kes glaukoma tersebut. Glaukoma sudut 
terbuka primer merupakan jenis glaukoma yang paling lazim tetapi glaukoma sudut tertutup 
primer merupakan bilangan yang lebih banyak di rantau Asia. Penyakit glaukoma ini 
kebiasaannya progres ke tahap lebih teruk; walaupun tekanan intraokular adalah terkawal. 
Faktor-faktor yang menyebabkan penyakit ini progres terbahagi kepada; faktor  boleh ubah dan 
tidak boleh ubah. Faktor boleh ubah termasuk amalan merokok and aktiviti fisikal. Walaupun 
terdapat beberapa bukti saintifik tentang hubung kait antara amalan merokok dan aktiviti fisikal 
ke atas penyakit glaucoma, tetapi tiada kajian yang berkaitan dengan tahap keterukkan penyakit 
ini. 
 
OBJEKTIF 
Kajian ini adalah bagi menilai hubung kait di antara amalan merokok dan aktiviti fisikal dengan 
tahap keterukan penyakit glaukoma sudut tertutup primer di kalangan pesakit berbangsa 
Melayu. 
 
KAEDAH KAJIAN 
Satu kajian rentas telah dijalankan yang melibatkan pesakit glaukoma sudut tertutup primer di 
antara April 2014 dan Ogos 2016 di klinik mata: Hospital Universiti Sains Malaysia (HUSM), 
Hospital Raja Perempuan Zainab II (HRPZ II), Hospital Kuala Lumpur (HKL), Hospital 
Sultanah Bahiyah (HSB) and Hospital Sultanah Nur Zahirah (HSNZ). Hanya pesakit glaukoma 
yang berbangsa Melayu dan dapat melakukan ujian medan penglihatan menggunakan analisis 
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Humphrey visual field 24-2 yang tepat secara berulang sekurang-kurangnya dua kali, telah 
dipilih. Tahap keterukan penyakit glaukoma adalah berdasarkan sistem skor ‘Advance 
Glaucoma Interventional Study’ (AGIS) yang telah dimodifikasi, ke atas ujian medan 
penglihatan. Tahap keterukan glaukoma ini terbahagi kepada ringan, sederhana dan teruk. 
Setiap subjek ditemuramah mengenai amalan merokok dan aktiviti fisikal oleh penyelidik 
utama secara bersemuka. Amalan merokok dan perinciaan berkenaan merokok adalah 
berdasarkan soalan kajiselidik “Singapore Malay Eye Study” (SiMES). Status perokok 
terbahagi kepada perokok aktif, perokok lama, perokok pasif, dan bukan perokok. Tempoh 
merokok dan bilangan rokok yang diambil dalam sehari turut direkodkan. Penilaian terhadap 
tahap aktiviti fisikal dibuat berdasarkan soalan kajiselidik “International Physical Activity 
Questionnaire (IPAQ)” yang telah divalidasikan ke dalam Bahasa Malaysia. Tahap aktiviti 
fisikal terbahagi kepada aktiviti ringan, sederhana dan aktiviti berat. Pengiraan kadar tenaga 
yang digunakan (METs) turut dikira berdasarkan jenis dan kekerapan aktiviti fisikal selama 7 
hari sebelum temuramah dijalankan. 
 
Analisa univariasi telah dibuat bagi memeriksa setiap faktor-faktor yang mempengaruhi tahap 
keterukan penyakit glaukoma ruang tertutup. Kaitan dan hubung kait antara amalan merokok 
dan aktiviti fisikal terhadap skor AGIS dibuat menggunakan “multiple linear regression” 
(MLR). 
 
KEPUTUSAN 
Seramai 150 pesakit glaukoma sudut tertutup primer (50 glaukoma ringan, 50 sederhana dan 
50 teruk) terlibat dalam kajian ini. Terdapat hubung kait yang signifikan di antara amalan 
merokok dan tahap keterukkan penyakit glaucoma (p = 0.044). Bilangan rokok yang dihisap 
turut menunjukkan hubung kait yang signifikan dengan tahap keterukkan penyakit glaukoma. 
xi 
 
Tetapi tempoh merokok (dalam kiraan tahun) tidak menunjukkan hubung kait yang signifikan 
dengan tahap keterukkan penyakit glaukoma. Bilangan rokok yang dihisap meningkatkan skor 
AGIS sebanyak 0.7 (ubahan b 0.65, 95% CI 0.27, 1.03, p = 0.001). 
 
Tahap aktiviti fisikal dan tahap keterukan glaukoma juga menunjukkan hubung kait yang 
signifikan (p <0.001). Aktiviti fisikal menunjukan perkaitan linear yang negatif yang signifikan 
dengan skor AGIS. Peningkatan aktiviti fisikal mengurangkan skor AGIS sebanyak 3.4 
(ubahan b -3.41, 95% CI -5.23, -1.59, p < 0.001). 
 
KESIMPULAN 
Amalan merokok dan aktiviti fisikal merupakan faktor risiko boleh ubah bagi tahap keterukan 
penyakit glaukoma sudut tertutup primer. Pengurangan atau berhenti merokok dan peningkatan 
aktiviti fisikal berpotensi untuk mengurangkan risiko peningkatan tahap keterukan penyakit 
glaukoma. Amalan hidup sihat di kalangan pesakit glaukoma dapat membantu dalam 
mengurangkan kerosakan saraf optik. 
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ABSTRACT 
 
INTRODUCTION 
Glaucoma is the leading cause of irreversible blindness worldwide, with Asians accounting for 
approximately half of the world’s glaucoma cases. Primary Open Angle Glaucoma is the most 
common form of glaucoma but Primary Angle Closure Glaucoma (PACG) constitute a higher 
number of cases in Asia. Progression of glaucoma is common; despite good control of 
intraocular pressure (IOP). Risk factors associated with progression of glaucoma can be non-
modifiable or modifiable. Research on identification of modifiable risk factors are scarce. 
Modifiable risk factors include cigarette smoking and physical activity. There are limited 
evidences on the potential association between cigarette smoking and physical activities on the 
development, progression, and severity of PACG.  
 
OBJECTIVE 
To determine the association between cigarette smoking and physical activity on the severity 
of primary angle closure glaucoma (PACG) in Malay patients. 
 
METHODOLOGY 
A cross-sectional study was conducted between April 2014 and August 2016 involving five 
ophthalmology clinics in Malaysia: Hospital Universiti Sains Malaysia (HUSM), Hospital Raja 
Perempuan Zainab II (HRPZ II), Hospital Kuala Lumpur (HKL), Hospital Sultanah Bahiyah 
(HSB) and Hospital Sultanah Nur Zahirah (HSNZ). Only Malay patients who were able to 
provide two consecutive reliable and reproducible Humphrey Visual Field (HVF) 24-2 
analyses were included. Severity of glaucoma was based on modified Advanced Glaucoma 
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Intervention Study (AGIS) scoring system on HVF and categorised into mild, moderate and 
severe glaucoma. 
 
Face to face interview was conducted to assess their smoking habits and physical activities. 
Their smoking status was obtained using validated questionnaires from Singapore Malay Eye 
Study (SiMES). Cigarette smoking was divided into active smoker, ex-smoker, passive smoker 
and non-smoker. Duration of smoking and number of cigarette smoked per day was 
documented. Physical activity status was assessed using validated Bahasa Malaysia version of 
International Physical Activity Questionnaire (IPAQ). Based on their physical activities over 
the past 7 days, PACG patients was categorised into mild, moderate and heavy physical 
activity. The duration of physical activity and measurement of energy requirement (METs) was 
also calculated. 
 
Univariate analysis was conducted to examine other risk factors for severity of glaucoma and 
AGIS score. The association of smoking and physical activity with AGIS score was analysed 
using multiple linear regression (MLR). 
 
RESULTS 
A total of 150 Malay patients were recruited (50 with mild, 50 with moderate and 50 with 
severe glaucoma). There was significant association between cigarette smoking and severity of 
glaucoma (p = 0.038). A significant association was also seen between the number of cigarette 
smoked and severity of glaucoma (p = 0.044). However, there was no significant association 
in duration of smoking (in years) with severity of glaucoma. Smoking do not appear to increase 
the AGIS score significantly but every increase in number of cigarette smoked increases the 
AGIS score by 0.7 (adjusted b 0.65, 95% CI 0.27, 1.03, p = 0.001). 
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There was significant inverse relationship between physical activity and AGIS score. Every 
increase in physical activity reduces the AGIS score by 3.4 (adjusted b -3.41, 95% CI -5.23, -
1.59, p < 0.001). 
 
CONCLUSION 
Cigarette smoking and physical activity are potential modifiable risk factor for severity of 
PACG. Cessation of cigarette smoking may help in halting the progression of glaucomatous 
visual field defect. Physical activity may protect against having more severe glaucoma. It is 
recommended that PACG patients practice healthier lifestyle to prevent progression of PACG. 
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Introduction  
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1.1 GLAUCOMA 
 
Glaucoma is a group of chronic progressive optic neuropathies characterised by slow 
progressive degeneration of the retinal ganglion cells and their axons, resulting in a specific 
appearance of the optic disc (structural) with corresponding pattern of visual loss (functional) 
(Weinreb & Khaw, 2004). The structural changes of optic nerves include excavation or cupping 
of the optic disc, thinning of the neuroretinal rim resulting in increased vertical cup-disc ratio 
(VCDR) and retinal nerve fibre layer (RNFL) defects. This is due to the loss of retinal ganglion 
cells and their axons as well as deformation of connective tissues supporting the optic disc 
(Burgoyne CF et al, 2005; Quigley HA, 2011). These structural changes lead to functional 
defects; progressive visual field defect (Yucel YH et al, 2001; Quigley HA, 2011). 
 
Glaucoma can be classified into two main groups according to the angle structure; closed angle 
glaucoma and open angle glaucoma (Coleman AL, 1999; Glaucoma Research Foundation, 
2012). Open and closed angle glaucoma can further be classified into primary or secondary 
glaucoma. Primary glaucoma, of open angle category includes Primary Open Angle Glaucoma 
(POAG), Juvenile Open Angle Glaucoma (JOAG), Normal Tension Glaucoma (NTG) and 
congenital glaucoma (Glaucoma Research Foundation, 2012).  The most common type may 
differ from one region of the world to another. For instance, Primary Angle Closure Glaucoma 
(PACG) is more prevalent in certain regions in Asia, whereas POAG is more equally 
distributed throughout the world and is the most common form of the disease (Quigley HA, 
1996). 
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1.2 PRIMARY ANGLE-CLOSURE GLAUCOMA 
 
The current classification of PACG is based on International Society of Geographical and 
Epidemiological Ophthalmology (ISGEO) definitions for glaucoma which was agreed on by 
the World Glaucoma Association (WGA) (Foster PF et al, 2002; Foster P et al, 2006). This 
classification places emphasis on evidence of glaucomatous optic neuropathy together with 
gonioscopic evidence and can be classified into three types; Primary angle closure suspect 
(PACS), Primary angle closure (PAC) and PACG. PACS is defined as an eye in which 180o or 
more appositional contact between the peripheral iris and posterior trabecular meshwork is 
considered possible with normal IOP, no peripheral anterior synechiae (PAS) and no evidence 
of glaucomatous optic neuropathy (GON). PAC is defined as an eye with 180o or more 
occludable drainage angle and features indication that trabecular obstruction by the peripheral 
iris has occurred, such as raised IOP of more than 21 mmHg, PAS, iris whirling, 
“glaucomflecken” lens opacities, or excessive pigment deposition on the trabecular surface in 
the absence of GON. The term PACG is used to indicate PAC eyes with GON (Foster PJ et al, 
2002; Foster P et al, 2006; European Glaucoma Society, 2014). 
 
GON can be classified according to three levels of evidence. Category 1, which provide the 
highest level of certainty, requires optic disc abnormalities (VCDR > 97.5th percentile of the 
normal population) and visual field defect consistent with glaucoma. In Category 2, if the visual 
field test could not be performed due to advanced loss of vision, glaucoma can be diagnosed 
on the basis of a severely damaged optic disc (VCDR > 99.5th percentile of the normal 
population). Lastly in Category 3, if the optic disc could not be visualized due to media opacity, 
a visual acuity < 3/60 and either IOP exceeding the 99.5th percentile of the normal population, 
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or evidence of previous glaucoma filtering surgery, would be sufficient to make the diagnosis 
(Foster PJ et al, 2002; Foster P et al, 2006). 
 
A majority of those with PACG presents as a chronic, asymptomatic form while the acute, 
symptomatic ones are seen in less than 25% of cases (Foster PJ et al, 2002; Quigley HA, 2011). 
Acute primary angle closure (APAC) is commonly considered as an ophthalmic emergency. It 
can present with the following symptoms including ocular or periocular pain, frontal headache 
on the side of affected eye, nausea and/or vomiting, a previous history of intermittent blurring 
of vision with haloes (Aung T et al, 2001; Glaucoma Research Foundation, 2012; European 
Glaucoma Society, 2014) and may be accompanied by the following signs such as conjunctival 
injection, corneal epithelial edema, mid-dilated unreactive pupil, and shallow anterior chamber 
(Aung T et al, 2001). Investigations will show raised IOP and presence of an occluded angle 
in the affected eye by gonioscopy (Aung T et al, 2001). 
 
1.2.1 Epidemiology of Primary Angle Closure Glaucoma 
 
According to a survey by the World Health Organization (WHO) in 2010, the 
approximated number of people visually impaired in the world is 285 million out of 
which 39 million are blind and 8% of all blindness is contributed to glaucoma (World 
Health Organization, 2012). Glaucoma is the second leading cause of blindness 
worldwide (Quigley & Broman, 2006; World Health Organization, 2012). Globally, an 
estimated 60.5 million people suffered from glaucoma in 2010 (Quigley & Broman, 
2006). Of these, an approximated 44.7 million had POAG and 15.8 million PACG 
(Quigley & Broman, 2006). The prevalence of glaucoma is expected to reach 79.6 
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million in 2020 with 58.6 million and 21 million of POAG and PACG respectively 
(Quigley & Broman, 2006).  
Based on a latest systemic review and meta-analysis, the overall prevalence of 
glaucoma for the population aged 40 to 80 years was 3.54% of which 3.05% was 
attributed by POAG and 0.50% by PACG in 2013 (Tham YC et al, 2014).  
 
A larger proportion of women are affected by glaucoma as seen in 59.1% of all people 
with glaucoma, 55.4% of OAG and 69.5% of ACG (Quigley & Broman, 2006). Women 
bear a greater burden than men because not only do women have a longer lifespan, but 
women also outnumber men (National Center for Health Statistics, 2009; Vajaranant 
TS et al, 2010; Central Intelligence Agency, 2016). Glaucoma being a disease of 
longevity, hence more women are seen to be affected. 
 
Bilateral blindness is seen in 3.9 million people with ACG in 2010, rising to 5.3 million 
people in 2020 (Quigley & Broman, 2006). Although only 24% of those with primary 
glaucoma have ACG, the amount of ACG blind is nearly identical to that of OAG due 
to the greater estimated morbidity of this disease (Quigley & Broman, 2006). 
 
Asia constitutes for a disproportionately higher number of PACG as opposed to the 
number of POAG cases which are more evenly distributed throughout the world 
(Quigley HA, 1996). Hence, the prevalence varies across geographical regions with the 
highest prevalence of PACG being Asia (1.09%; 95% CI, 0.43-2.32) (Tham YC et al, 
2014). Based on the prevalence models by Quigley and Broman (2006), in 2010 higher 
prevalence of PACG cases are seen in Asian countries; China 1.26%, Southeast Asia 
1.20%, India 0.80%. However, the prevalence of PACG in Japan and Middle East are 
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estimated to record lower than average; 0.39% and 0.16% respectively (Quigley & 
Broman, 2006). Therefore, Asians represents 87% of the 15.7 million with ACG 
(Quigley & Broman, 2006). 
 
1.2.2 Prevalence of Primary Angle Closure Glaucoma in Malay populations 
 
Asians are a heterogenous population, a melting pot. It is no surprise that there is 
variation in disease prevalence among Asian population. Various epidemiologic 
population-based studies in East Asia and Southeast Asia shows variation in the 
prevalence of PACG; Chinese 1.3% (He M et al, 2006), Mongol 1.4% (Foster PF et al, 
1996), Thai 0.9% (Bourne RR et al, 2003), Nepal 0.39% (Thapa SS et al, 2012). 
Numerous population based studies conducted across India showed the prevalence of 
PACG ranges between 0.29% to 4.3% (Jacob A et al, 1998; Dandona L et al, 2000; 
Ramakrishnan R et al, 2003; Raychaudhuri A et al, 2005; Vijaya L et al, 2006, Palimkar 
A et al, 2008). 
 
Malays account for 5% of the world’s population. Although there are approximately 
300 million to 400 million people of Malay ethnicity living in Asia (Population 
Reference Bureau, 2016), the burden, causes, risk factors and epidemiology of blinding 
eye diseases in this ethnic group are surprisingly lacking. Most knowledge about eye 
disease has been derived from Chinese, Japanese and Indian population, but little 
knowledge is known in Malay population. 
 
According to the data released by the Department of Statistics, Malaysia, the population 
of Malaysia was 28,334,135, making it the 42nd most populated country. The population 
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of Malaysia consists of many ethnic groups. Malays make up the majority with 50.4% 
of the population, while indigenous ethnic groups (known as Bumiputera) make up 
another 11% (Population Distribution and Basic Demographic Characteristics 2010. 
Department of Statistics, Malaysia). 
 
Based on the Singapore Malay Eye Study (SiMES), a population based study that 
screened 3280 Malay participants residing in Singapore, aged 40 to 80 years, the 
prevalence of PACG in Malays is 0.12% (Shen SY et al, 2008). In Malaysia, glaucoma 
emerged as the fifth leading cause of both blindness and low vision based on the 
National Eye Survey 1996 (Zainal M et al, 2002). This represents to roughly 1.8% of 
all bilateral blindness and 1.8% of all low vision in our country’s population (Zainal M 
et al, 2002). Whilst the number is much smaller compared to cataract (39.1% of 
blindness and 39.5% of low vision) and refractive error (4.1% of blindness and 48.3% 
of low vision), the results of the survey should not be taken at face value. This is because 
the sample size of 18,027 participants was too small for subgroup analysis for the results 
to be representative of the country’s population. In addition, poor response rate of 69% 
may sway the results to certain causes. Furthermore, the examination was done at the 
respondent’s home with no access to slit lamp examination, gonioscopy or visual field 
assessment. Glaucoma was also poorly defined as presence of horizontal cup-disc ratio 
of 0.4 or more with an IOP of 22 mmHg or more, taken with a Perkins tonometer. All 
these factors contribute to the underestimation of the prevalence of glaucoma. It is 
therefore likely that the figure reported by Zainal et al (2002) is only the tip of the 
iceberg. Currently, there are no statistics on prevalence of glaucoma in Malaysia 
(Clinical Practice Guidelines, 2008). 
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1.3 GLAUCOMA PROGRESSION AND SEVERITY 
 
Glaucoma is a chronic progressive disease resulting in optic nerve head damage that requires 
lifelong monitoring (Brusini and Johnson, 2007). Glaucomatous damage can be quantified 
using either structural (changes in the optic nerve and RNFL) or functional loss (visual field 
defects), or a combination of both (Brusini and Johnson, 2007; Medeiros FA et al, 2012a). The 
rate of progression varies highly among patients (Leske MC et al, 2007, Rossetti L et al, 2010). 
Disease progression in glaucoma is common and despite treatment, majority of patients still 
progress (Rossetti L et al, 2010). 
 
1.3.1 Progression of Primary Angle Closure Glaucoma 
 
Based on a retrospective hospital based study, the incidences of progression from PACS 
to PAC, PACS to PACG, PAC to PACG and, mild and moderate PACG to advanced 
PACG were 14%, 11.5%, 19.0% and 33% respectively in Malays after at least 5 years 
of follow up (Liza-Sharmini AT et al, 2014a). The incidence of progression from PACS 
to PAC and PAC to PACG were lower when compared to a prospective study on the 
Indian population; 22% and 28.5% respectively (Thomas R et al, 2003a; Thomas R et 
al, 2003b). The difference between the two studies may be attributed to the differences 
in the methodology, where prospective study can provide a more accurate outcome 
compared to a retrospective one. 
 
The presence of APAC seems to protect against the progression towards development 
and progression of glaucomatous optic neuropathy to a certain extend (Ang LPK et al, 
2004). Only 17.5% of symptomatic eyes (history of APAC) developed end stage VF 
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defects. In contrast, 52.8% of eyes without history of APAC (asymptomatic) developed 
end-staged VF defects at initial presentation (Ang LPK et al, 2004). Similar finding was 
observed in Malay patients; 15% of asymptomatic angle closure were blind and 30.5% 
were at an advanced stage of glaucoma (Liza-Sharmini et al, 2014a). The severity of 
VF defects in PACG patients could be due to the asymptomatic nature of the disease 
similar to POAG (Lee YH et al, 2004, Chakrabarti S et al, 2007). The presence of APAC 
may create better awareness that lead to earlier detection of the disease but do not 
prevent against progression of the disease; 33% of eyes with APAC progressed to 
develop glaucomatous changes (Liza-Sharmini et al, 2014a). In addition, lack of 
awareness and poor health care system may also play a role in late presentation of 
PACG (Eke T et al, 1999; Saw SM et al, 2003; Hennis A et al, 2007; Altangerel U et 
al, 2009). Deficiency of awareness may be due to increasing age, lack of formal 
education, unemployment, illiteracy and poor accessibility to health care system (Saw 
SM et al, 2003). 
 
1.3.2 Monitoring glaucoma progression 
 
In clinical practice, monitoring of disease progression is done using serial evaluation of 
longitudinal series of visual field (functional) measurements (Kirwan JF et al, 2014, 
Saunders LJ et al, 2014). Standard automated perimetry (SAP) is the most common 
method for assessing VF in glaucoma and has been widely used for many years (Heijl 
A, 1989; Chauhan BC, 2008). SAP can be used to measure the rate of glaucoma 
progression (Chauhan et al, 2008). The European Glaucoma Society also recommended 
SAP as the measuring tool for progression in clinical practice (European Glaucoma 
Society, 2014).  
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The progression of glaucoma can also be monitored by the structural changes of the 
optic nerve head (ONH). With the advancement of technology, newer and more 
sophisticated ophthalmic imaging devices have been introduced such as, Heidelberg 
retinal tomograph (HRT) and optical coherence tomograph (OCT). These non-invasive 
imaging tools provide us with quantitative images and allows for precise observation, 
documentation and monitoring of the ONH, RNFL and inner macular layer (Medeiros 
FA et al, 2012b; Kirwan JF et al, 2014). However, it is important to not establish 
progression of glaucoma solely on quantitative images alone but to determine 
progression on the agreement and correspondence between structural progression and 
functional deterioration (Musch DC et al, 2009; Leung CKS et al, 2011; Kirwan JF et 
al, 2014). 
 
1.3.3 Evaluation of visual field progression 
1.3.3.1 Trend-based Analysis 
 
Currently, evaluation of visual field progression can be done using trend-based analysis 
and event-based analysis of SAP (Birch MK et al, 1995; Spry and Johnson, 2002; Heijl 
A et al, 2002; Diaz-Aleman VT et al, 2009). Trend-based analysis is based on the rate 
of progression of the visual function of the eye through a linear regression model using 
a new global index; visual field index (VFI) (Casas-Llera P et al, 2009; Rao HL et al, 
2013). The VFI is the gross percentage of visual function for a given field at each point 
where the visual thresholds are estimated. VFI is calculated from pattern deviation (PD) 
plots in eyes with mean deviation (MD) of better than – 20 dB and from total deviation 
plots in eyes with MD worse than – 20 dB (Rao HL et al, 2013). Central visual field 
points are more heavily weighted, therefore trend-based analysis becomes more 
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sensitive to detect change in visual field that are more severely abnormal (Giraud JM et 
al, 2010). VFI analysis was also found to be more accurate than the traditional MDI 
analysis for determining rate of progression and is considerably less affected by cataract 
or cataract surgery (Bengtsson and Heijl, 2008). Major limitations of trend-based 
analysis are the length of follow-up and the number of HVF test required to detect 
progression (Caprioli J, 2008; Rao HL et al, 2013). In general, VFI trend-based analysis 
take longer to detect progression but do so with higher specificity, and they become 
more useful as the disease becomes more severe (Giraud JM et al, 2010; Rao HL et al, 
2013).  
 
1.3.3.2 Event-based Analysis 
 
The event-based analysis is essentially to detect the occurrence of progression at certain 
point (Caprioli J, 2008). Glaucoma progression analysis (GPA) software incorporated 
in Humphrey Visual Field Analyser (HVA) (Carl-Zeiss Meditec, Dublin, CA) is an 
example of event-based analysis (Casas-Llera P et al, 2009). GPA uses statistical 
criteria designed for the Early Manifest Glaucoma Trial to detect progression of VF 
defects (Leske MC et al, 1999). When the pattern deviation probability maps show a 
significant deterioration at the same three or more points on two consecutive follow-up 
test, the GPA will detect this as “possible progression”; if significant deterioration is 
seen at the same three or more points in three consecutive follow-up tests, GPA shows 
this as “likely progression”. The software flags as “no progression detected” if the 
above two criteria are not met (Rao HL et al, 2013). Nouri-Mahdavi K et al compared 
GPA with VFI and Advanced Glaucoma Intervention Study (AGIS) method in 
predicting VF progression and found that GPA predicted outcomes better (Nouri-
12 
 
Mahdavi K et al, 2007). The event-based GPA analysis is capable of detecting 
progression earlier compared to trend VFI analysis by 7 months (Casas-Llera P et al, 
2009). A primary limitation of event-based analysis is in detecting progression of defect 
in the central 10 degrees (Diaz-Aleman VT et al, 2009; Arnalich-Montiel F et al, 2009). 
Hence, event-based analyses are more likely to detect progression earlier and are more 
sensitive ((Nouri-Mahdavi K et al, 2007; Casas-Llera P et al, 2009). 
 
1.3.4 Staging the severity of glaucoma 
 
Staging the severity of glaucoma enhances the management of the glaucoma towards 
individualized treatment (Susanna Jr. and Vessani, 2009). It is therefore essential to 
standardize the glaucoma severity scoring to provide a common understanding for both 
clinical and research purposes (Susanna Jr. and Vessani, 2009). The staging of 
glaucomatous damage can be classified into mild, moderate, and advanced or severe 
based on either structural or functional loss criteria, or a combination of both (Susanna 
Jr. and Vessani, 2009). 
 
The most common method used to quantify glaucomatous damage is using serial HVF 
evaluation (Brusini and Johnson, 2007). At baseline, it detects and quantifies damage, 
and in subsequent follow-up of a glaucoma patient, it detects stability or progression of 
the disease over a period of time (Susanna Jr. and Vessani, 2009). To quantify the 
severity of glaucomatous damage using analysis of structural damage to the ONH and 
RNFL is still under evaluation (Brusini and Johnson, 2007).  
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Various staging systems using SAP have been proposed such as Aulhorn and 
Karmeyer’s classification (Greve E, 1982; Brusini and Johnson, 2007); Functional 
Vision Score system (Colenbrander A et al, 1992); Quigley’s Grading scale (Quigley 
HA et al, 1996); Hodapp-Parrish-Anderson (HPA) classification (Hodapp E et al, 
1993); Glaucoma Staging System (GSS) (Brusini P, 1996); Advanced Glaucoma 
Intervention Study (AGIS) (Investigators AGIS, 1994). 
 
1.3.4.1 Hodapp-Parrish-Anderson (HPA) classification 
 
HPA classification system considers two criteria: the overall extent of damage and on 
the defect(s) proximity to the fixation point (Susanna Jr. and Vessani, 2009). HPA uses 
both the mean deviation (MD) value and the number of defective points in the 
Humphrey Statpac-2 pattern deviation probability map of the 24-2 on SITA-standard 
HVF analysis (Susanna Jr. and Vessani, 2009). This classification is popular due to the 
ease in assessment. However, HPA characterized the visual field defect into four 
relatively course stages and does not give information about the location and depth of 
the defect(s) (Susanna Jr. and Vessani, 2009). In addition, it requires an accurate and 
time-consuming analysis of every single visual field result (Brusini and Filacorda, 
2006). 
 
1.3.4.2 Advanced Glaucoma Intervention Study (AGIS) staging 
 
A continuous glaucoma staging systems has been recommended by the Advanced 
Glaucoma Intervention Study (AGIS). In this scoring system, severity of glaucoma can 
be quantified using the Humphrey 24-2 threshold test. The AGIS visual field defect 
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score is based on the number and depth of clusters of adjacent depressed test sites in the 
upper hemifield, lower hemifield and in the nasal area of the total deviation plot (an 
event-based analysis) (Investigators AGIS, 1994; Ng M et al, 2012). The scores for each 
hemifield and nasal area are summed up and visual field scores are divided into five 
categories: 0 = normal visual field; 1-5 = mild damage; 6-11 = moderate damage; 12-
17 = severe damage; and 18-20 = end stage (Investigators AGIS, 1994). This staging 
system provide standardized classification of visual field according to severity (Nouri-
Mahdavi K et al, 2004). Thus, it is very useful for scientific and clinical research. 
However, it is time-consuming, requires special training and not practical for day-to-
day clinical usage (Brusini and Johnson, 2007). 
 
1.3.4.3 Glaucoma Staging System (GSS) 
 
The GSS is a modified version of the HPA system. It is based on MD and Corrected 
Pattern Standard Deviation (CPSD) values, the location and number of points depressed 
on the pattern deviation plot, the Glaucoma Hemifield Test (GHT) from HVF and plot 
the values on a Cartesian coordinate diagram (Brusini and Johnson, 2007; Ng M et al, 
2012). Stage of glaucoma damage can be determined by the intersection of MD and 
CPSD values on the diagram. GSS has a total of 6 stages: Stage 0 (normal visual field); 
Stage 1 (early field defect); Stage 2 (moderate field defect); Stage 3 (advanced field 
defect); Stage 4 (severe field defect) and Stage 5 (end-staged disease) (Ng M et al, 
2012). GSS not only provide information of stage of glaucoma damage but the type of 
damage sustained whether generalized, mixed or focal. GSS is quick and able to provide 
the specific visual field damage (Koçak I et al, 1997). However, GSS is unable to 
provide information on location, shape or morphology of the visual field defects. 
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1.3.4.4 Enhanced Glaucoma Staging Score 
 
Enhanced GSS (e-GSS) is a modified and improved system of GSS (Brusini and 
Filacorda, 2006). The major limitations of GSS; non-mutually exclusive criteria 
between stages (narrow band between Stage 0 and Stage 1) which may result in some 
fields classified ambiguously, and the need to recalculate the PSD values, if corrected 
indices are not available (Brusini and Filacorda, 2006). There was a strong association 
between e-GSS and AGIS and HAP systems in staging the severity of glaucoma 
(Brusini and Filacorda, 2006). There was also a good correlation of e-GSS with a 
classification based on the Bebié curve (Brusini and Filacorda, 2006).  
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1.4 RISK FACTORS FOR PROGRESSION AND SEVERITY OF PRIMARY ANGLE  
      CLOSURE GLAUCOMA 
 
PACG is known to cause more blindness compared to POAG. Identification of factors affecting 
the progression and severity of PACG is essential, to prevent further acceleration of the disease. 
However, there is minimal knowledge on the factor affecting progression and severity of 
PACG. Various studies focused on the risk factors affecting development of PACG (Senthil S 
et al, 2008; Garudadri C et al, 2010; Li and Cui, 2012, Hsu WC et al, 2014). The risk factors 
can be divided into non-modifiable and modifiable risk factors. 
 
Advancing age is a known non-modifiable risk factor for developing PACG (Drance 
SM, 1997). This is evident by numerous population-based prevalence studies carried 
out globally (Foster PJ et al, 2000; Dandona L et al, 2000; Buhrmann RR et al, 2000; 
Bonomi L et al, 2000; Baskaran M et al, 2015). The prevalence of PACG in a rural 
southern Indian population showed that the odds for PAC and PACG increased with 
age after adjusting for sex (Vijaya L, 2006). The prevalence of PACG for the age group 
40 to 49 years was 0.63% (95% CI, 0.24 to 1.01) and increased to 2.97% (95% CI, 1.72 
to 4.23) for those 70 years and above (Song WL et al, 2011).  
 
Age is also identified as a risk factor for progression of PACG. For each year increase 
in age increases the risk of disease progression by 1.02 folds (95% CI, 0.98 to 1.06) in 
Malay patients with PACG (Liza-Sharmini AT, 2014a). Studies by Thomas R et al 
reported the 5-year incidence of PACS progressing to PAC was 22% and PAC 
progressing to PACG was 28.5% (Thomas R et al, 2003a; Thomas R et al, 2003b, Sihota 
R, 2011). 
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As discussed earlier, race is another risk factor for PACG. PACG is approximately three 
times more common in Asians compared to European-derived populations (He M et al, 
2006). Among Asians; Mongolian and Chinese populations tend to be affected more, 
while variable prevalence is seen in Southeast Asia and India (He M et al, 2006). A 
meta-analysis of 29 published studies on Asian populations with PACG showed a 
strong association of prevalence with ethnic group through meta-regression analysis (β 
= 0.27, p = 0.009) (Cheng JW et al, 2014). However, there are minimal available data 
on race as a risk factor for progression of PACG. A study by Liza-Sharmini AT et al 
comparing Malay and Chinese ethnics in Malaysia reported that Malay patients 
presented with a more advanced disease and a higher tendency to progress within two 
years (Liza-Sharmini et al, 2014b).  
 
Women are more at risk to develop PACG (Graham and Hollows, 1966; Lai JS et al, 
2001; Vijaya L et al, 2006; Shen SY et al, 2008; Wang YX et al, 2010; Song WL et al, 
2011; Liza-Sharmini AT et al, 2014a). Based on meta-analysis of 29 published studies 
on Asian populations, overall female to male ratio of PACG prevalence was 1.51:1 
(95% CI, 1.01 to 2.28) (Cheng JW et al, 2014). However, there was no published data 
on the effect of gender on progression of PACG. 
 
Higher incidence of PACG in women is mainly due to their ocular biometry (Chen HB 
et al, 1998; Wong TY et al, 2001; Congdon NG et al, 2002; George R et al, 2003; 
Wickremasinghe S et al, 2004; Ramani KK et al, 2007). PACG eyes are smaller in axial 
length (AL), have flatter corneas, shallower anterior chamber depth (ACD) and thicker 
lenses (Lowe RF, 1970; Alsbirk PH, 1976; Marchini G et al, 1998; Sihota R et al, 2008). 
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Eyes with shorter AL will tend to have thicker lenses sited more forward. Growth of 
the lens continues throughout life leading to increase in lens thickness and further 
anterior lens displacement which results to a shallowing of ACD (Lowe RF, 1970). 
Patient with PACG was found to have ACD that is 1.0 mm shallower than non-disease 
eyes, of which, 0.65 mm of shallowing attributed by the whole lens being anteriorly 
positioned and 0.35 mm by increased in lens thickness (Lowe RF, 1970). 
 
A positive family history of PACG is an additional risk factor. The inheritance of PACG 
is believed to be polygenic (Lowe RF, 1972; Alsbrik PH, 1982; Wilensky JT et al, 
1993), although both autosomal dominant and recessive inheritance pattern are seen in 
pedigrees with high prevalence of PACG. A study on Chinese population found that the 
disease prevalence among first-degree relatives of PACG patients, only parents account 
for an odd ratio of 8.76 (95% CI, 2.00 to 38.32) (Kong X et al, 2011). Characteristic-
adjusted odds ratio of family history for PACG was 4.82 (95% CI, 2.08 to 11.19] and 
for severity of PACG was 1.61 (95% CI, 1.05 to 2.49) (Kong X et al, 2011).  
 
It has also been observed that siblings of patients with angle closure have substantially 
higher risk of angle closure as compared to siblings of individual with open angles. The 
estimated odds of angle closure 21.1 times higher (95% CI, 2.8 to 160.1) among siblings 
of PACS, PAC or PACG (Venkatesh R et al, 2012). A high heritability of narrow angles 
of almost 60% was found (Amerasinghe N et al, 2011). Siblings of Chinese patients 
with PAC or PACG have almost a 50% probability of having narrow angles and are 
more than 7 times more likely to have narrow angles than the general population 
(Amerasinghe N et al, 2011). 
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PACG is a complex disease. Based on huge multiple population genetic study, 
rs11024102 in PLEKHA7; rs3753841 in COL11A1 and rs1015213 located between 
PCMTD1 and ST18 on Chromosome 8q were identified as potential genetic 
susceptibility markers (Visthana EN et al, 2012). Genetic marker was also identified 
that may associate with ocular biometry: anterior chamber depth; that increase the 
susceptible to ocular biometry changes to induce the development of PACG (Nongpiur 
ME et al, 2014). However, there is no susceptible genetic markers that may associate 
with the progression of PACG (Li et al, 2015). 
 
IOP remains the only modifiable risk factor for development and progression of 
glaucoma. It is the basis of treatment for glaucoma. Mean IOP for PACG was found 
higher than POAG (Gazzard G et al, 2003; Lee YH et al, 2004). Fluctuation of IOP was 
higher in PACG compared to POAG (Gazzard G et al, 2003; Lee YH et al, 2004). Thus, 
it is perhaps the reason for acceleration of glaucomatous damage in PACG. The quest 
to identify other modifiable risk factor is still ongoing. 
 
Hence, many hypothesis of modifiable risk factors have been proposed, these includes: 
physical activity (Williams PT, 2009), cigarette smoking (Williamson TH et al, 1995; 
Takashima Y et al, 2002; Kang JH et al, 2003; Lee AJ et al, 2003; Bonovas S et al, 
2004; Edwards R et al, 2008; Wang D et al, 2012; Chiotoroiu SM et al, 2013; Jain V et 
al, 2016), body mass index (BMI) (Pasquale and Kang, 2009; Pasquale LR et al, 2010; 
Berdahl JP et al, 2012), mean arterial blood pressure (Bulpitt CJ et al, 1975; Klein BE 
et al, 2005; Xu L et al, 2007; Werne A et al, 2008), caffeine (Higginbotham EJ et al, 
1989; Chandrasekaran S et al, 2005; Kang JH et al, 2008; Pasquale and Kang, 2009) 
and alcohol intake (Klein BE et al, 1993; Chiotoroiu SM et al, 2013).  
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It is interesting to note that all of these risk factors are strongly associated with our 
lifestyle, so perhaps by changing our way of life, the risks of developing and 
progression of glaucoma may be lowered. Therefore, an in-depth knowledge to these 
modifiable risk factors is of utmost importance to identify alternative measures that can 
be taken to prevent its onset and to sustain vision in diseased eyes in the presence of 
normal IOP. So far, the evidence of these proposed risk factors is still inconclusive. I 
won’t be elaborating on the proposed modifiable risk factors raised above, but paying 
particular attention to cigarette smoking and physical activities which are the objective 
of this dissertation. 
 
1.4.1 Cigarette smoking 
 
Cigarette smoking is known to cause many diseases, such as cardiovascular disease, 
diabetes mellitus, lung disease and carcinoma (Solberg Y et al, 1998; Cheng ACK et al, 
2000; Gallo V et al, 2009; Menvielle G et al, 2009). It is also associated with various 
ocular diseases such as age-related macular degeneration, cataract, and for the 
development and progression of thyroid eye disease (Solberg Y et al, 1998; Thornton J 
et al, 2005; Kelly SP et al, 2005; Thornton J et al, 2007; Lois N et al, 2008; Cong R et 
al, 2008). Studies on the effect of cigarette smoking on either intraocular pressure or 
glaucoma showed contradictory results (Wilson MR et al, 1987; Klein BE et al, 1993; 
Mansouri K et al, 2015).  
 
 
 
21 
 
1.4.1.1 Relationship between cigarette smoking and glaucoma 
 
In 1976, a study conducted by Mehra et al reported following the last inhalation of a 
cigarette smoke, there was an acute rise in IOP that was statistically significant (Mehra 
KS et al, 1976). The Blue Mountains Eye Study observed a modest cross-sectional 
positive association between current smokers and IOP (Lee AJ et al, 2003). This was 
supported by another study which showed a higher mean IOP in smokers in relation to 
non-smokers (Afshan A et al, 2012). Numerous other studies have also found a positive 
association between smoking and increased IOP (Wu and Leske, 1997; Yoshida M et 
al, 2003; Yoshida M et al, 2014; Kamble G et al, 2016). The increase in IOP from has 
been supported by transcranial Doppler ultrasound studies which demonstrated faster 
ophthalmic artery blood flow after nicotine administration (Rojanapongpun and 
Drance, 1993). 
 
In a case-control study, it was found that current cigarette smoking has a statistically 
significant associated with glaucoma with an odd ratio (OR) of 2.9 (95% CI, 1.3 to 6.6) 
(Wilson MR et al, 1987). A systematic review of 11 studies by Edwards et al (2008), 
which included 9 case-control studies, 1 cohort study, and 1 pooled analysis of 2 cohort 
studies, found little evidence of a compelling or consistent association between cigarette 
smoking and glaucoma. In 6 of the 9 case-control studies, ORs varied from 0.7 to 1.4 
(Morgan and Drance 1975; Reynolds DC, 1977; Katz & Sommer, 1988; Charliat G et 
al, 1994; Stewart WC et al, 1994; Juronen E et al, 2000). Only the study by Fan BJ et 
al (2004) found a strong association between smoking and glaucoma, with an OR of 
10.8 (95% CI; 1.9 to 63.0), the wide CI reflecting the small number of cases in the 
study, approximately 32 cases. 
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The Beaver Dam Eye Study did not find any association between cigarette smoking and 
prevalence of glaucoma (Klein BE et al, 1993). While in Iran, NilForooshan N et al 
(2008) also observed no association between cigarette smoking and glaucoma. In their 
case control study, smoking had an OR of 1.81 (95% CI; 0.74 to 4.41) towards 
developing glaucoma. This value however, was not statistically significant (p = 0.184). 
 
1.4.1.2 Mechanisms of how cigarette smoking increases the risk of glaucoma 
 
Various mechanisms have been postulated concerning the potential biologic association 
of cigarette smoking with glaucoma. In the mid-1970s, Mehra et al, in their research on 
effects of smoking on aqueous humor dynamics, noticed a rise of IOP of more than 5 
mmHg after the last puff of a cigarette in 37.1% of primary glaucoma patients and only 
11.4% in normal persons – a statistically significant difference. They proposed that 
cigarette smoking causes vasoconstriction which lead to a rise in episcleral venous 
pressure, thereby inhibiting aqueous outflow from the angle (Mehra KS et al, 1976). 
 
Cigarette smoking has a strong effect on IOP in normotensive individual as 
demonstrated in a clinical study by Timothy and Nneli (2007). They found positive 
effect of smoking with systolic blood pressure readings (Timothy and Nneli, 2007). A 
number of studies have shown increase in IOP corresponds to the degree of arterial 
blood pressure (Sharrett AR et al, 1999; Wong TY et al, 2003; Smith W et al, 2004). 
Thus, smoking results in fluctuation and uncontrolled IOP which may lead to the 
progression of visual field defects to a more severe glaucoma. 
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Cardiovascular disease and its predictors, including diabetes mellitus, have been 
associated either with elevated IOP or with glaucomatous visual field loss (Klein and 
Klein, 1981; Klein BE et al, 1984), suggesting that cigarette smoking, with its known 
effects on vascular disease, must be considered. The levels of plasma fibrinogen are 
known to rise with age (Hume R, 1961; Moser and Hajjar, 1966). Chronic smoking 
may induce hyperfibrinogenaemia, as apparent by the accentuation of this rise in 
cigarette smokers (Ogston D et al, 1970). Bearing in mind the effect of smoking in 
producing oxidative stress and damage to the small vessels (Jensen JA et al, 1991), 
smoking may be indicted in the aggravation of factors related to glaucoma. 
 
It has been reported that arterial blood flow to the optic nerve head are compromised in 
smokers (Williamson TH et al, 1995; Kaiser HJ et al, 1997). Cigarette smoking plays a 
part in the development of vascular disease by causing occlusion of the arterial lumina 
from atherosclerosis and intimal thickening. Free-radical-mediated oxidative stress in 
cigarette smoking play a pivotal role in the development of atherosclerosis (Gibbons 
and Dzau, 1994; Kojda and Harrison, 1999; Nedeljkovic ZS et al. 2003). The vascular 
dysfunction caused by smoking is initiated by reduced nitric oxide (NO) bioavailability 
and further aggravated by the increased expression of adhesion molecules and 
subsequent endothelial dysfunction (Kojda and Harrison, 1999; Messner and Bernhard, 
2014). Increased adherence of platelets and macrophages provokes the development of 
a pro-coagulant and this induces an inflammatory environment (Messner and Bernhard, 
2014). Subsequent to trans-endothelial migration and activation, macrophages consume 
oxidized lipoproteins arising from oxidation modifications and differentiate into foam 
cells (Messner and Bernhard, 2014). Furthermore to direct physical damage to 
endothelial cells, smoking induces tissue remodelling, and prothrombotic processes 
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together with activation of systemic inflammatory signals, all of which contribute to 
atherogenic vessel wall changes (Messner and Bernhard, 2014). Inadequate blood flow 
reduces vascular supply of nutrient and oxygen to optic nerve head causing 
glaucomatous neuropathy. 
 
The precise toxic components of cigarette smoking and the mechanism involved in the 
development of ocular diseases is not clearly understood. The high concentration of 
free radicals in particulate (tar) and gas phases are believed to play an important role 
(Ambrose and Barua, 2004). This oxidative stress damages the ocular tissues, 
particularly, the ganglion cells in optic nerve head leading to an acceleration of 
glaucomatous damage (Tezel G, 2006; Nita M and Grzybowski A, 2016). In addition 
to the direct effect of free radicals from the cigarette smoke, it can also result in the 
activation of endogenous source of free radicals, such as nitric oxide synthase (NOS), 
xanthine oxidase, and nicotinide adenine dinucleotide phosphate (NADPH) oxidase, 
etc. Hence, smoking leads to increase in oxidative stress, reduction in NO generation 
and bioavailability, and activation of inflammatory process resulting in the initiation 
and progression of tissue damage (Ambrose and Barua, 2004). 
 
1.4.1.3 Smoking status 
 
A meta-analysis of several epidemiological studies on smoking observed a higher risk 
of developing glaucoma for current smokers as compared to ex-smokers (Bonovas S et 
al, 2004). A pooled OR for the risk of glaucoma seen with current smoking was 1.37 
(95% CI, 1.00 to 1.87) from a meta-analysis comprising of 3 cross-sectional studies and 
3 case-control studies (Bonovas S et al, 2004). In contrast, meta-analysis from 2 cross-
